WuXi AppTec (OTCMKTS:WUXIF – Get Free Report) is anticipated to announce its results after the market closes on Monday, October 26th. Analysts expect WuXi AppTec to announce earnings of $0.4375 per share and revenue of $2.39 billion for the quarter.
WuXi AppTec Price Performance
WuXi AppTec stock opened at $24.98 on Friday. The stock’s 50 day moving average price is $26.29 and its 200 day moving average price is $21.03. WuXi AppTec has a one year low of $13.60 and a one year high of $29.10.
WuXi AppTec Company Profile
WuXi AppTec is a China-based contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. The company provides integrated services that help customers discover, develop, test and manufacture medicines and healthcare products.
Its offerings include drug-discovery research, medicinal chemistry, biology, preclinical and clinical development, analytical and regulatory testing, and manufacturing of active pharmaceutical ingredients, drug products and advanced therapies.
Featured Stories
- Five stocks we like better than WuXi AppTec
- Spotify Soars After Earnings as the Company Touts AI Benefits and Moderating Costs
- Lockheed Martin’s Record $292 Billion Backlog Comes With a Delivery Test
- Palantir’s Next Big Test Isn’t a Partnership—It’s the Numbers
- Kinder Morgan’s $4.7 Billion Pipeline Bet Could Be Bigger Than Its Earnings Beat
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
